Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Abstract
CONTEXT: The polycystic ovary syndrome (PCOS) is the most common endocrine abnormality of reproductive-aged women today, affecting approximately 6.6% of unselected reproductive-aged women (approximately 4 million women in the United States) (1990 National Institutes of Health criteria), and potentially represents a significant financial burden to our health care. OBJECTIVE: The objective of the study was to define, using current definitions and prevalence or incidence data, the minimal economic burden that PCOS in reproductive-aged women represents for the United States. DESIGN: The study design was a literature review. SETTING: The study was conducted at a tertiary care center. PATIENTS OR OTHER PARTICIPANTS: There were no patients or other participants. INTERVENTION(S): We performed a systematic review of the published medical literature to identify studies evaluating epidemiology of reproductive-age PCOS and its clinical consequences and costs. We tied general societal cost data for the different health consequences to reproductive-age PCOS costs, using prevalence data. MAIN OUTCOME MEASURE(S): The main measure in the study was total health care-related economic costs. RESULTS: We estimated the mean annual cost of the initial evaluation to be dollar 93 million (2.1% of total costs), that of hormonally treating menstrual dysfunction/abnormal uterine bleeding to be dollar 1.35 billion (31.0% of total), that of providing infertility care to be dollar 533 million (12.2% of total), that of PCOS-associated diabetes to be dollar 1.77 billion (40.5% of total), and that of treating hirsutism to be dollar 622 million (14.2% of total). CONCLUSIONS: The total cost of evaluating and providing care to reproductive-aged PCOS women in the United States is dollar 4.36 billion. Because the cost of the diagnostic evaluation accounted for a relatively minor part of the total costs (approximately 2%), more widespread and liberal screening for the disorder appears be a cost-effective strategy, leading to earlier diagnosis and intervention and possibly the amelioration and prevention of serious sequelae.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“comprehensive screening and counseling from physicians and greater public awareness can curtail morbidity and reduce the economic burden on both the patient and the healthcare system.”
From 'I'm usually being my own doctor': women's experiences of managing polycystic ovary syndrome in Canada (2023) · cites this paper as [61]
In the citing paper
“PCOS has a high healthcare-related economic burden”
From 'I'm usually being my own doctor': women's experiences of managing polycystic ovary syndrome in Canada (2023) · cites this paper as [61]
In the citing paper
“Also from a resource allocation perspective, the financial costs related to diagnosis of PCOS are only a small fraction (2%) of the total costs associated with comprehensive care for PCOS in the United States (32).”
From Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome (2016) · cites this paper as [32]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Self-citationMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Self-citationAsunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Self-citation
Cited by
Items 401–500 of 556
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_8 · Cited by 4
Self-citationEconomic Burden of Polycystic Ovary Syndrome
Riestenberg, C. K., Jagasia, A., & Azziz, R. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_22 · Cited by 3
Self-citationDashti, S., Eftekhar, M., Sarikhani, D., & Tabibnejad, N. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_128_24 · Cited by 2
“As listed in Table 2, pregnancy rates, abortion rates, intrauterine fetal death, and live birth rates did not show statistically significant differences between the two groups [Table 2].”
Li, H., Jing, Z., Li, R., Shen, Z., Bai, T., & Song, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1662823 · Cited by 2
“This not only affects the health of patients but also increases the economic burden on healthcare systems (11, 12).”
A review of hyperandrogenism state in polycystic ovarian syndrome
Mohamed Shabi, M., Nivya, P. S., Devika, C., Reddy, M. S., Poornima, N., R., R. K., Joseph, J., & Kolageri, S. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20233666 · Cited by 3
IoT Based Monitoring System for Health During Menstruation
Khadse, C., Hajare, S., Sheikh, N., Dahule, R., & Kate, P. (2025) · International Conference on Sentiment Analysis and Deep Learning (ICSADL) · doi:10.1109/icsadl65848.2025.10933142 · Cited by 2
Excluded, not dismissed: Enhancing benefit in clinical research
Nardell, M., Chhabra, A., & Pal, L. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.08.013 · Cited by 2
“Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ark-text $w aterm ark-text $w aterm ark-text such as diabetes and cardiovascular disease (CVD) [1].”
BackgroundInfluentialYu, H., Chen, D., Yang-zhi, L., Li, C., Liu, Y., & Xie, M. (2013) · PubMed · Cited by 3
Polycystic Ovarian Syndrome: A Complex Affair Centered on Ovarian Hyperandrogenism
Crum, C. P., & Meserve, E. E. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.03912-5 · Cited by 2
Haider, S., Mannan, N., Khan, A., & Qureshi, M. A. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Sharma, P., Gupta, A., & Purohit, P. (2015) · Journal of Cardiovascular Disease Research · doi:10.5530/jcdr.2015.2.4 · Cited by 2
Maryamsup, K. K., Pour, N. A., Safari, A., & Roozegar, R. (2012) · doi:10.5897/jcmr11.086 · Cited by 4
“Some (Mastorakos et al., 2006; Aziz et al., 2005) believe that PCOs has substantial psychological, social and economic consequences and is associated with the development of a number of sequelae, including increased risk of glucose intolerance (gestational and type II diabetes).”
BackgroundInfertility in women with polycystic ovary syndrome and the role of metformin in management
Boyle, J. A., Teede, H. J., & Misso, M. L. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2013.842689 · Cited by 2
Ultrasonography and diagnosis of polycystic ovary syndrome
Nagamani, M., & Chilvers, R. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776854.011 · Cited by 2
Chronic Disease and Polycystic Ovary Syndrome: Are they Related?
Varanasi, V. K. (2012) · Journal of Women s Health Care · doi:10.4172/2167-0420.1000e101 · Cited by 2
“36 billion is spent annually in diagnosis and treatment of the PCOS [7].”
BackgroundTaghavi, M., Ali, S. M., Fahimeh, A., & Rokni, H. (2011) · Iranian journal of diabetes and obesity · Cited by 11
Update on Polycystic Ovary Syndrome: What Dermatology Nurses and Nurse Practitioners Need to Know
Carron, R. (2016) · Journal of the Dermatology Nurses’ Association · doi:10.1097/jdn.0000000000000259 · Cited by 3
Tessaro, I., Modina, S., Lodde, V., Sivelli, G., Franciosi, F., Terzaghi, L., Luchini, P., Rumio, C., & Luciano, A. M. (2017) · PubMed Central · Cited by 2
Rajendiran, L., Nandeesha, H., & Thyagaraju, C. (2021) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_179_20 · Cited by 2
“[11] IntroductIon P ovary syndrome (PCOS) is a common heterogeneous endocrine and metabolic disorder affecting 6%–8% of women of reproductive years.[1] Although the etiology of PCOS is still unclear, it is considered as a multifactorial disorder.”
BackgroundThe effect of body mass index on neonatal outcomes in Chinese women with polycystic ovary syndrome
Guo, H., Wang, B., Gao, H., & Zhu, Q. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.996927 · Cited by 2
Christou, M., Mintziori, G., Goulis, D. G., & Tarlatzis, B. C. (2023) · ISGE series · doi:10.1007/978-3-031-22378-5_8 · Cited by 3
Zaki, M. E., Kholoussi, S., Ismail, S. M., Raouf, H. A., Helwa, I., Hassan, N. A.-M., Youness, E. R., Mohamed, N., Kamal, S., Yousef, W., et al. (2015) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2015.05.007 · Cited by 4
“[19], described a higher prevalence of hyperandrogenemia in women with concomitant PCOS and MS, other study concluded that DHEAS correlated inversely with arterial structure, suggesting possible cardioprotective effects of endogenous DHEAS in women with PCOS [35].”
ResultMaboudi, A., Shafizade, S., Amiri, F. N., Qujeq, D., Mohammadpour, R. A., Moaddabi, A., Amiri, M., Bahnemiri, M. G., & Yosefnia-Pasha, S. (2020) · Research Square · doi:10.21203/rs.3.rs-56300/v1 · Cited by 2
Nabi, M. M. U., Pathan, M. F., Barua, M., Kabir, M. M., Alam, J., & Jannut, K. M. (2019) · BIRDEM Medical Journal · doi:10.3329/birdem.v10i1.44757 · Cited by 3
Polikistik Over Sendromuna Multidisipliner Yaklaşım
Elgün, T. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub80.c269 · Cited by 1
Liang, Q. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.105239 · Cited by 1
Prediction of exposure to pollutants and hormones on the risk of polycystic ovarian syndrome
Hou, W., Dong, J., Yao, Y., Zhang, P., Zhang, G., Mou, P., Guan, J., & Wang, Y. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-01981-7 · Cited by 1
“In 2006, based on U.S. data and traditionally lower prevalence estimates, the expected economic burden of PCOS in Australia was AUD 400 million (with PCOS-related diabetes accounting for 40% of the total costs), highlighting its significant health and economic impact [4].”
Palomba, S., Costanzi, F., Seminara, G., Caserta, D., & Aversa, A. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag005 · Cited by 1
“That increased risk, in combination with its long-term cardiometabolic comorbidities, is a health condition that imposes a heavy economic burden on the health care system (Azziz et al. , 2005; Riestenberg et al. , 2022).”
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Mcgowan, M., Cowan, S., Tay, C. T., McGowan, M. Μ., & Ng, A. H. (2026) · Experimental Physiology · doi:10.1113/ep092880 · Cited by 1
“Insulin resistance can result in hyperinsulinaemia, which can be associated with weight gain, suppressing lipolysis and promoting lipogenesis in adipocytes (Thomas et al., 1979), with adiposity likely to exacerbate hyperinsulinaemia (Azziz et al., 2005).”
The Role of Diet and Lifestyle Modification in the Treatment of Polycystic Ovary Syndrome
Thomson, R. L., Teede, H. J., Stepto, N. K., Banting, L., & Moran, L. (2015) · CRC Press eBooks · doi:10.1201/b18190-3 · Cited by 3
Clinical and Hormonal Evaluation of Androgen Excess
Azziz, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_33 · Cited by 1
Self-citationThe Polycystic Ovary Syndrome Status - A Risk Factor for Future Cardiovascular Disease
Ilie, I. R. P., Ilie, R., MOCAN, L. C., Georgescu, C. E., Duncea, I., Mocan, T., Ghibu, S., & Iancu, C. (2012) · InTech eBooks · doi:10.5772/32072 · Cited by 1
“PCOS thus constitutes a significant health and economic burden estimated at over $4 billion in the USA with ∼40.5% of costs related to treatment of type 2 DM. (Azziz et al., 2005).”
BackgroundInfluentialOrief, Y. I., Darwish, E. A. E., Elsamra, M. A., & Ragab, D. H. A. (2013) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2013.06.003 · Cited by 1
Синдром поликистозных яичников. Официальное заявление Европейского общества эндокринологии
Conway, G. S., Dewailly, D., & Diamanti‐Kandarakis, E. (2015) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2015.25.32-52 · Cited by 1
The Relationship between Clinical and Chemical Hyperandrogenism in 14-18-Years- Old Girls
Akbarzadeh, M., Naderi, T., Dabbaghmanesh, M. H., Tabatabaee, H., & Zareh, Z. (2012) · Zahedan Journal of Research in Medical Sciences · Cited by 1
Polycystic ovary syndrome and fertility
Goldenberg, N., & Glueck, C. J. (2013) · doi:10.2217/ebo.12.175 · Cited by 1
Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
Reid, R. L. (2015) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/2/4/00132 · Cited by 1
“Polycystic ovary syndrome is a term that encompasses a variety of phenotypes and has been associated with both reproductive (oligomenorrhea, acne, hirsutism, androgenic alopecia, infertility, endometrial hyperplasia and malignancy) and metabolic (dyslipidemia, diabetes, Non-Alcoholic Fatty Liver (NAFLD), Non alcoholic…”
BackgroundIntroduction to Biological and Psychobiological Aspects of PCOS
Barry, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30290-0_1 · Cited by 1
Neuroendocrinology of Female Reproduction
Wilkinson, M., & Imran, S. A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108149938.004 · Cited by 1
Mousa, B. A. (2020) · Medico-Legal Update · doi:10.37506/mlu.v20i2.1150 · Cited by 6
“8%) in the first community-based prevalence study based on current Rotterdam diagnostic criteria (14), while in our study the prevalence of PCOS in Iraqi women in AL-Hilla city was estimated about 33%, which is higher than the percentage in the world .”
BackgroundManni, A., & Quarde, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-49872-6_6 · Cited by 1
An Insight on Polycystic Ovary Syndrome (PCOS) and Use of Herbal Medicines as Alternative Treatment
Rao, S. K. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4808-0.ch006 · Cited by 3
Médicalisation et autonomie des femmes affectées par le syndrome des ovaires polykystiques
Doudenkova, V. (2021) · Canadian Journal of Bioethics · doi:10.7202/1077630ar · Cited by 1
“Aux États-Unis, les coûts liés au SOPK et les problèmes de santé que ce syndrome implique sont estimés à 4,36 milliards de dollars par an (3).”
BackgroundElsaid, N. (2016) · Journal of Gynecological Research and Obstetrics · doi:10.17352/jgro.000014 · Cited by 1
“Gonadotropin induction is widely utilized for ovulation stimulation in clomiphene citrate resistant PCOS women [8].”
BackgroundGhosh, K., Chakraborty, S., Chatterjee, D., & Bandyopadhyay, A. R. (2023) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2023.4.12 · Cited by 1
The Efficacy of Biopsychosocial-Spiritual Model for Women with Polycystic Ovary Syndrome
Munir, S., Perveen, F., & Munir, M. (2024) · CARC Research in Social Sciences · doi:10.58329/criss.v3i1.89 · Cited by 1
Polycystic Ovary Syndrome and Labor Market Attachment: Sequence Analysis
Boldis, B. V., Grünberger, I., Helgertz, J., & Cederström, A. (2025) · International Journal of Public Health · doi:10.3389/ijph.2025.1607889 · Cited by 1
“Research has demonstrated that PCOS is associated with several reproductive, cardiovascular, metabolic, psychological and dermatological conditions [9 – 13], and impaired overall quality of life [14].”
Sharma, P., Achrekar, V., & Purkait, R. (2025) · Journal of Integrated Standardized Homoeopathy · doi:10.25259/jish_36_2024 · Cited by 1
Reply: How many of the items in the polycystic ovary syndrome can be validated statistically?
Azziz, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.11.002 · Cited by 1
Self-citationPolycystic Ovary Syndrome, Obesity and Insulin Resistance
Cassar, S. (2014) · Victoria University Research Repository (Victoria University) · Cited by 1
Ding, T. (2018) · UCL Discovery (University College London) · Cited by 1
Sukhapure, M. (2019) · Otago University Research Archive (University of Otago) · Cited by 7
Síndrome dos ovários policísticos: correlação dos fenótipos com as manifestações metabólicas
das Neves, E. M. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-05112013-123657 · Cited by 1
de Melo, A. S. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2009.tde-26092013-165328
Research Resource: The Endometrium Database Resource (EDR)
Darlington, Y. F., Jeong, J., Lee, K. Y., Franco, H. L., Chen, E. S., McOwiti, A., Mistretta, T., Steffen, D. L., Becnel, L. B., & DeMayo, F. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1250
Rosenfeld, J. A. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511642111.010
Illness Perceptions of Polycystic Ovary Syndrome
Baker, E. A. (2014) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Angonese, N. T. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Al-Waeli, A. M., & AL-Khalisi, M. H. (2015) · Advances in life science and technology
Lifestyle interventions in women with PCOS: the role of a pulse-based diet
Serrao, S. B. (2013) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 2
Polycystic ovarian disease in adult and perimenopausal women
(2014) · Healthy Aging Research · doi:10.12715/har.2014.3.8
“It has been reported that PCOD affects 2 to 8% of population [6, 7].”
BackgroundGenetic Analyses of Polycystic Ovary Syndrome
Urbanek, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_5
[Proteomics and PCOS: Is it here the missing link? Literature review].
Ruiz, I. O. C., de la Llata, E. S., Sánchez, M. R. M., Hernáez, M. L., Gutierrez‐Blazquez, M. D., & Sarrió, A. R. (2015) · PubMed · Cited by 1
Role of the Dietitian in Multidisciplinary Treatment of Polycystic Ovary Syndrome
Thompson, W. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.547
Unravelling the link between insulin resistance and androgen excess
O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
DuRant, E. (2010) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3515
Ultrasonography in infertility
Rizk, B. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776854.010
Simões, R. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-12012016-105532
Dietary management of Polycystic ovary syndrome.
Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Routray, P. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i12.84
“J Ped and Adolesc Gyn 2003;16(1):33–7.”
Management des polyzystischen Ovarsyndroms (PCOS) in verschiedenen Lebensphasen
Bachmann, A. (2019) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-019-0076-2
Sathiya, S., Renuka, S., Famida, A. M., Jennifer Britto, J., Vijayalakshmi, K., & Sailatha, R. (2019) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20193806 · Cited by 2
“Polycystic ovarian syndrome was first described by Stein and Leventhal in 1935.(1) Polycystic ovarian syndrome is a disorder of heterogeneous androgen excess with varying degrees of metabolic and reproductive abnormalities.”
BackgroundManagement des Syndroms polyzystischer Ovarien in der Peri- und Postmenopause
Bachmann, A. (2019) · Gynäkologische Endokrinologie · doi:10.1007/s10304-019-00272-3
GIycemic Index and Women’s Health
Philippou, E. (2016) · CRC Press eBooks · doi:10.1201/9781315371764-11
Barya, S., & Babel, M. (2019) · Obsgyne Review Journal of Obstetric and Gynecology · doi:10.17511/joog.2019.i04.05
Vaghela, S., & Kotak, P. (2019) · Obsgyne Review Journal of Obstetric and Gynecology · doi:10.17511/joog.2019.i04.02
Polycystic ovarian syndrome: need for life course approach
Dahiya, N., Bharti, A., Vats, K., & Bachani, D. (2020) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20203018
Meikle, A. W. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70196-3
Teenage Reproductive Health: Pregnancy, Contraception, Unsafe Abortion, Fertility
Odland, J. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-062-0
Polycystic Ovarian Syndrome and Diabetes Mellitus: What's New?
Nasr, M. Y., Alhuqayl, T. A., Alshammari, H. A., Alkhudhayri, H., Alzin, M. B., & Sulimani, R. A. (2021) · Journal of Nature and Science of Medicine · doi:10.4103/jnsm.jnsm_140_20
A CROSS SECTIONAL STUDY OF POLY CYSTIC OVARIAN SYNDROME (PCOS) AMONGST ADOLESCENT GIRLS IN LUCKNOW.
Johri, N., & Kumar, P. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/4025441 · Cited by 1
Patten, R. K. (2021) · Victoria University Research Repository (Victoria University) · Cited by 5
Sabzmakan, L., Rajapour, R., & Kordasiabi, M. C. (2020) · doi:10.21203/rs.2.23725/v1
“4 billion is spent on PCOS and related complications, and more than 40% of this cost is dedicated to the treatment of reproductive disorders (infertility and menstrual dysfunction), and other 40% is dedicated to the diabetes related to PCOS (5).”
BackgroundJapanese Culture and the Japanese--Regional Variations and Recent Chganges
祖父江, 孝. (1994) · 学術月報
Kalhor, M., Mohammadi, E., Shahali, S., Amini, L., & Moghaddam‐Banaem, L. (2019) · Research Square · doi:10.21203/rs.2.11164/v1
ERTÜRK, B., Pabuçcu, R., Yılmaz, N., Bostancı, E. İ., Tımur, H., Pabuçcu, E., Arslanca, T., & Keskin, M. (2021) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2020-80730
An Update on Polycystic Ovary Syndrome
Trivax, B., & Azziz, R. (2007) · US Endocrinology · doi:10.17925/use.2007.00.1.84 · Cited by 1
Self-citationAn Insight on Polycystic Ovary Syndrome (PCOS) and Use of Herbal Medicines as Alternative Treatment
Rao, S. K. (2022) · IGI Global eBooks · doi:10.4018/978-1-6684-6299-7.ch007
Eiras, M. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-10022023-174306
Akciğer Kanserine Moleküler Terapötik Yaklaşım
Bayrak, B. Y. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub80.c356
Hematolojik Malignitelerde Sitogenetiğin Tanısal ve Terapötik Yönleri
Şahin, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub80.c359
Cywes, R., Kajee, H., Wellington, N., Cucuzzella, M. T., Riley, K., Isaacs, D. M., Pataguana, N., Lake, I., Rauch, L., McKelvey, S., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821617-0.00010-3
Hareesh, A. S., Divya, D. S., & Prathima, P. (2023) · International Journal of Nursing Education and Research · doi:10.52711/2454-2660.2023.00040
Einführung in biologische und psychobiologische Aspekte des PCOS
Barry, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-24461-2_1
Metadata
- Authors
- Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P.
- Affiliations
- Cedars-Sinai Medical Center (US)
- ORCID
- Azziz, Ricardo
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-08
- Volume
- 90
- Issue
- 8
- Pages
- 4650-4658
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2118575626
- Cited by
- 537
- References
- 90
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 29 · 2023: 28 · 2022: 36 · 2021: 45 · 2020: 25 · 2019: 41 · 2018: 27 · 2017: 27 · 2016: 22 · 2015: 20 · 2014: 27 · 2013: 24 · 2012: 26
- FWCI
- 18.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (K24-D01346)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD029364, R01-HD29364)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- polycystic ovary syndrome, economic burden, health care costs, women of reproductive age, infertility treatment, hirsutism, abnormal uterine bleeding, menstrual disorders, PCOS screening, cost estimation
- MeSH terms
- Adolescent, Adult, Female, Humans, Polycystic Ovary Syndrome, United States, Incidence, Prevalence, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.